Back to IVBXFView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Target Indication
Neovascular Age-related Macular Degeneration
Clinical Trial
NCT07275840Last updated: 6/24/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Aflibercept OphthalmicPhase 3
Neovascular Age-related Macular Degeneration
Bortezomib for InjectionPhase 3
Relapsed or Refractory Multiple Myeloma
Investigator's choice of therapyPhase 3
Colorectal Cancer
PicankibartPhase 3
Plaque Psoriasis
tegafur, Gimeracil and Oteracil Potassium CapsulesPhase 3
Resectable Gastric/Gastroesophageal Junction Adenocarcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts